Apixaban for Extended Treatment of Provoked Venous Thromboembolism.
Saved in:
| Title: | Apixaban for Extended Treatment of Provoked Venous Thromboembolism. |
|---|---|
| Authors: | Piazza G; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Bikdeli B; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston.; Yale New Haven Hospital, Yale Center for Outcomes Research and Evaluation, New Haven, CT., Pandey AK; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Krishnathasan D; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Khairani CD; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Bejjani A; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh., Morrison RH; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Hogan H; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Rashedi S; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Pfeferman M; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Lou J; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Fanikos J; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Department of Pharmacy, Brigham and Women's Hospital-Harvard Medical School, Boston., Porio N; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston., Rosenbaum L; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston., Sobieszczyk P; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Lan Z; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Center for Clinical Investigation, Brigham and Women's Hospital-Harvard Medical School, Boston., Gerhard-Herman M; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Campia U; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Goldhaber SZ; Thrombosis Research Group, Brigham and Women's Hospital-Harvard Medical School, Boston.; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston. |
| Corporate Authors: | HI-PRO Trial Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2025 Sep 25; Vol. 393 (12), pp. 1166-1176. Date of Electronic Publication: 2025 Aug 30. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
